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Abstract 
Liposomes containing negatively-charged phospholipid, N-palmitoylphosphatidylethanolamine (NPPE) were examined for stability in 
the presence of human serum, using the release of the entrapped 5,6-carboxyfluorescein as an aqueous marker. Either small unilamellar 
vesicles (SUV) or large unilamellar vesicles (LUV) were used. Incorporation of NPPE into PC SUV decreases leakage in the presence of 
serum or phosphate-buffered saline, no strictly related to size increase observed and to the surface negative charge present. The stabilizing 
effect of NPPE and Chol were synergistic. Inhibition of destabilization induced by serum of PC/Chol liposomes was observed when 
NPPE concentrations were above 12 mol%. Change in the membrane fluidity or incorporation of a monosialoganglioside into liposomes 
do not significantly change the half-life of liposomes in the presence of a high NPPE concentration. I corporation of NPPE into PC/Chol 
liposomes increases membrane rigidity which does not change after serum incubation. The presence of NPPE in liposomes decreases lipid 
transfer/exchange between liposomes and lipoproteins although the same amount of serum proteins were incorporated as in PC/Chol 
liposomes. As expected, these proteins are accessible to trypsin digestion. In accordance with these results, the liposome agglutination 
assay shows no steric barrier activity. As a whole, the results obtained in this paper suggest a complex mechanism for stabilization of 
NPPE containing liposomes in human serum. 
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1. Introduction 
The use of liposomes as delivery systems has been 
studied extensively in recent years due to their therapeutic 
efficacy and the reduction of toxicity [1,2]. However, their 
potential use as drug carriers by intravenous injection is 
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limited by their low stability in the bloodstream. Firstly, 
phospholipid exchange and transfer to lipoproteins, mainly 
HDL, destabilizes and disintegrates liposomes, with subse- 
quent loss of content [3,4]. Moreover, liposomes are elimi- 
nated from circulation by association with certain plasma 
proteins, called opsonins, which promotes macrophage 
uptake, or by direct union to the cell surface and ultimate 
phagocytosis by macrophages in liver and spleen [5]. 
The stability of liposomes has been widely studied 
through experiments in vitro and in vivo. This stability in 
the presence of serum is a first approximation to the 
behaviour of liposomes in biological fluids. Several abora- 
tories have tried to obtain liposomes with long circulation 
time and which can be targeted to non-reticulo endothelial 
system tissues in a specific manner. By manipulation of 
some liposome properties uch as lipid composition [6,7], 
particle size [6,7] and surface charge [8], improved results 
have been obtained. 
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The inclusion of lipids with long and saturated hydro- 
carbon chains in these liposomes, which contain choles- 
terol (Chol), increases their half-life and decreases the 
liposome leakage [4], inhibits the phospholipid exchange 
of liposomes with HDL [9-11] and association with serum 
proteins, which facilitates the uptake of liposomes by the 
reticulo endothelial system (RES) [12,13]. 
Liposomes with a shielded negative charge, like phos- 
phatidylinositol, GM1 [12-14] or with phospholipids cova- 
lently coupled to a hydrophilic polymer poly(ethylene 
glycol) [15] leak less and the union of some plasma protein 
is impaired, therefore these liposomes can avoid uptake by 
the mononuclear phagocytic system (MPS) and achieve 
longer circulation times. 
In order to find liposomes with long circulation time, 
we propose the introduction of a natural tricatenary, nega- 
tively-charged phospholipid, N-acylphosphatidylethanola- 
mine (N-acylPE). This was found as minor constituent in a 
wide spectrum of life forms [16] including mammalian 
cells and tissues [17,18]. But they can accumulate under 
pathological conditions involving degenerative membrane 
changes, as in the infarcted areas of canine myocardium 
after coronary artery ligation [19,20]. In these tissues, 
N-acylPEs have long N-acyl chains, mainly saturated (16:0 
and 18:0) [16]. 
Although there are few studies on the physical proper- 
ties of N-acylPEs, it has been observed that a N-acyl chain 
containing 10 or more carbon atoms penetrates the bilayer 
and increases of the hydration degree of interracial and 
phosphate regions [21-23]. This results in a bilayer stabi- 
lizing effect on unsaturated phosphatidylethanolamine 
which is a non-bilayer lipid [21,23,24]. In our laboratory 
we have also observed that incorporation of N-acylPE with 
a long N-acyl chain into eggPC liposomes produces a 
decrease in permeability due to an increase in rigidity 
caused by the third hydrocarbon chain, a surface modifica- 
tion and a size increase [25]. 
In this paper, we have examined the effect of incorpora- 
tion of N-acylPE of natural origin to liposomal bilayers on 
serum-induced leakage of liposome contents in vitro. With 
these experiments, we demonstrate hat the incorporation 
of N-acylPE to liposomes can provide them with a long 
half-life in the presence of serum due to the changes in 
fluidity and surface modification observed previously. 
Moreover, the fact that N-acylPE is present only as a 
minor component in biological membranes suggests that 
its exchange may be limited which would increase stabil- 
ity. N-PalmitoylPE (NPPE) was used for several reasons. 
Palmitoyl is the N-acyl fatty acid found in greatest propor- 
tion and this lipid can torm stable closed vesicles with a 
size near 100 nm [25]. We have tested the effect of 
incorporation of NPPE in small unilamellar liposomes 
(SUV) and in large unilamellar liposomes (LUV), based on 
eggPC. We have also tested the effect of incorporation of 
GM1, which helps to avoid uptake by the RES, and the 
importance of system fluidity. 
2. Materials and methods 
2.1. Materials 
Egg yolk phosphatidylcholine (PC), transphosphatidyl- 
ated egg yolk phosphatidylethanolamine, hydrogenated gg 
yolk phosphatidylcholine (HPC), N-biotinylPE and bovine 
brain phosphatidylserine (PS) were purchased from Avanti 
Polar Lipids. Bovine brain sphingomyelin (SPH), bovine 
brain monosialoganglioside (GM1) and bovine serum albu- 
min (BSA) and streptavidin were from Sigma and choles- 
terol (Chol), palmitoyl chloride and TLC plates were from 
Merck. 6(5)-Carboxyfluorescein (CF), from Eastman- 
Kodak, was purified as described elsewhere [26]. Ficoll, 
Sephadex-G50, SDS-PAGE gel electrophoresis and the 
molecular weight standards for electrophoresis were from 
Pharmacia. 1,6-Diphenyl-l,3,5-hexatriene (DPH) and its 
ammonium salt (TMA-DPH) were obtained from Molecu- 
lar Probes. All inorganic reagents were analytical grade 
and aqueous olutions were made up with double distilled 
water and deionized water. Human serum was obtained 
from clotted transfusion blood obtained from the Secci6n 
de Hematologia of Clinica Asepeyo, Barcelona. Before use 
the serum was clarified by centrifugation for 2 min in a 
Heraeus microfuge. 
2.2. Synthesis and characterization of NPPE 
NPPE was synthesized from transphosphatidylated egg 
yolk phosphatidylethanolamine and purified as described 
elsewhere [25]. The final product was characterized by 
proton-NMR, IR spectroscopy and fatty acid composition 
(data not shown). Lipid concentrations were determined by 
phosphorus analysis [27]. 
2.3. Preparation of unilamellar vesicles 
The lipid films were hydrated in 2 ml of phosphate- 
buffered saline pH 7.4 (PBS) or of CF 50 mM in PBS (the 
osmolarity of the CF solution was adjusted to 320 
mosM/kg with PBS, pH 7.4). Small unilamellar vesicles 
(SUV) were prepared by sonication of a lipid suspension 
following a standard procedure [25]. In order to obtain 
vesicles of a definite size, the lipid suspensions were 
extruded through polycarbonate filters of definite size 
(manufactured by Nuclepore) using an extrusion device 
(Lipex Biomembranes) [28]. Non-encapsulated CF was 
separated from liposomes on a spin column of Sephadex 
G-50 medium with isotonic PBS as eluent. Liposomes of 
different composition were characterized by particle size 
analysis (determined by dynamic laser light scattering 
using a PCS41 optics unit, Malvern Autosizer IIC) and 
entrapped volume determination i  1/mol lipid (obtained 
by the ratio of fluorescence of encapsulated CF in non- 
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quenching conditions and lipid concentration quantified by 
phosphorus analysis [29]). 
2.4. Liposome stability assay 
An aliquot (40-50 /xl) of CF-liposomal suspension 
(50-120 nmol as total lipids) was added to 450 /xl of 
prewarmed (37 ° C) human serum (lipid/serum ratio of 0.1 
/zmol/ml) or PBS (pH 7.4). At different imes, 10 ~1 of 
the suspensions were diluted 200 times with PBS and the 
fluorescence intensity (hex = 492 nm and )tern = 520 nm) 
was measured using a Kontron SFM25 spectrofluorimeter 
before and after liposome lysis. To lyse liposomes, 100/xl 
of 5% deoxycholate was added. Low liposome concentra- 
tions were chosen in order to approximate the ratio of 
liposomes to the serum components which would be ex- 
pected if liposomes were injected in vivo [14]. 
Release of the entrapped dye from liposomes was calcu- 
lated from the equation described by Liu and Huang [30]. 
Half-lives (T1/2) for CF leakage in the presence or absence 
of human serum were determined by the technique of 
Allen and Cleland [31]. The kinetics of leakage was linear 
on a semi-logarithmic plot for all compositions assayed. 
2.5. Association of serum components with liposomes 
To determine serum protein binding to liposomes, we 
used a method escribed by Liu and Huang [30]. Unilamel- 
lar vesicles without CF and extruded through 0.1 /xm pore 
size were used. Briefly, aliquots of liposomes (5 /xmol of 
lipids) were incubated with the same volume of human 
serum at 37°C for 1 h. The unbound proteins was sepa- 
rated on discontinuous gradient of Ficoll (in PBS, pH 7.4) 
by centrifugation i  a Beckman L-70 ultracentrifuge with a 
swinging-bucket 40-TI rotor for 1 h at 10 000 rpm at room 
temperature. The liposomes which floated at the PBS/15% 
Ficoll interface were collected and subjected once more to 
an identical procedure. In the collected suspension the 
protein concentration was determined using the BCA pro- 
tein assay (Pierce) with BSA as standard. As control, in all 
our experiments human serum without liposomes was 
treated in the same way. The absorbance of the blanks was 
always lower than 15% of that of the samples. The same 
samples were used for analysis of proteins bound to lipo- 
somes. The proteins were solubilized [32] and subjected to 
SDS-PAGE electrophoresis, using 7.5% polyacrylamide 
under denaturing conditions [33] in a Phast-System elec- 
trophoretic apparatus (Pharmacia LKB Biotechnology), 
followed by silver staining. Prestained SDS-PAGE molec- 
ular weight standards were used to estimate the molecular 
weights of the proteins. Lipid compositions of incubated 
liposomes were examined by extraction of the lipids [34] 
followed by TLC analysis on silica gel plate using chloro- 
form/methanol/water (65:25:4) as developing solvent. 
The individual phospholipid content was determined by a 
phosphorus assay [27] and the cholesterol was quantified 
using the Boehringer-Mannheim Kit based on an enzy- 
matic method (Chol oxidase) [35]. 
2.6. Interaction of serum components with liposomes 
Liposomes treated in the same way as those in the 
preceding section were separated from excess of serum 
proteins by chromatography on Bio-Gel A-15M, 200-400 
mesh size (Bio-Rad), in spin columns as described by 
Chonn et al. [36]. 100 ~1 of liposome/serum incubation 
mixtures was then applied and immediately centrifuged 
(2000 rpm, 1 min at 4 ° C). Column fractions were col- 
lected in glass tubes by applying 100 ~1 of PBS. The 
liposomes, usually, eluted within the first 2-5 fractions 
and did not present serum protein contamination. The 
column fractions were analyzed for protein content as 
described above. 
Aliquots of serum-treated liposomes (0.26 /zmol in 0.2 
ml of PBS) were further incubated with equal volume of 
PBS containing trypsin (0.26 mg/ml) for 1 h at 37 ° C. 
Trypsin inhibitor (0.35 mg/ml final) was added to stop the 
reaction. Liposomes were chromatographed as described, 
to remove free proteins. 
Aliquots of serum-treated and trypsin-treated liposomes 
were diluted to a final concentration of 0.25 mg/ml  and 
labelled with DPH and TMA-DPH for 1 h at 40 ° C. The 
molar ratio of probes to lipid was 1:375. Fluorescence 
depolarization of probes in liposomes was measured by a 
similar method to that described by Shinitzky and Baren- 
holz [37]. The fluorescence was measured with excitation 
at 360 nm and emission at 430 nm. In all experiments, 
corrections of light-scattering blank were made by measur- 
ing the excitation/emission ratio in the absence of the 
fluorophore. 
2. 7. Agglutination assay 
Large unilamellar vesicles were prepared from 
PC/Chol /NAPE (with different molar ratio) and 2.5% 
N-biotin-cap-PE. 50 /xl liposomes (1 mg/ml) were mixed 
with 0.5 ml PBS in a microcuvette and 5 /xg streptavidin 
was added. Increase in turbidity was monitored as the 
optical density at 440 nm [8]. 
3. Results 
The stability of the liposome preparations used was 
tested by photon correlation spectroscopy. The liposome 
preparations, stored at 4 ° C, were stable for at least a week 
without any change in their structure (mean diameter and 
size distribution), which is the longest ime for which they 
were used (data not shown). 
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Table 1 
Effect of incorporation f NPPE, Chol or their combination  the stability of PC-based liposomes 
Lipid composition T1/2 (h) a Dmea n a 
(molar atio) buffer serum (nm) 
Trapped volume a 
(1/mol) 
PC 15.4 _+ 1.7 0.4 _+ 0.1 40.2 _+ 3.5 0.43 + 0.08 
PC/Chol 2:1 46.8 -1- 4.7 10.4 + 2.3 56.1 + 2.4 0.62 + 0.14 
PC/NPPE 10:1 30.7 ± 2.2 0.7 _+ 0.1 43.5 _+ 3.0 0.48 _+ 0.12 
PC/NPPE 3:1 45.4 _+ 4.9 13.7 _+ 2.9 58.2 + 2.5 0.65 _+ 0.13 
PC/Chol/NPPE 12:7:2 79.2 _+ 3.3 48.7 + 5.0 73.4 _+ 5.8 0.87 +_ 0.16 
PC/Chol/NPPE 6:4:2 89.0 _+ 4.7 111.8 + 13.5 91.6 + 6.5 1.10 _+ 0.22 
PC/Chol/NPPE 4:3:2 94.7 _+ 6.0 116.0 _+ 14.3 98.4 _+ 6.9 1.36 _+ 0.19 
a Results are expressed as means + S.D. (n > 5), n = number of assays. 
3.1. Effect of NPPE on the stability of liposomes in human 
serum 
Stability studies were performed in vitro in buffer (PBS) 
or in the presence of human serum at 37 ° C at l ip id/serum 
ratio of 0.1 /zmol l ip id /ml  serum. As reference system we 
used SUV of PC, well characterized in the bibliography 
[4,14]. As expected, the leakage of aqueous solute from 
liposomes containing only PC was higher in the presence 
of serum than in buffer (Table 1). T1/2 for leakage of CF 
from SUV composed by PC/NPPE with different molar 
ratios was determined (Table 1). Incorporation of 9 mol% 
NPPE to PC liposomes decreased the leakage 2-fold in the 
presence of serum or buffer. Increase in NPPE concentra- 
tion up to 22 mol% raised T1/2 28-fold in serum, but the 
increase was less marked in buffer. This stabilization is 
higher than observed for 33 mol% Chol (Table 1), in 
accord with previous studies [4,31]. 
Incorporation of 33 mol% Chol and 10 mol% negative 
charge improved stability of l iposomes in biological fluids 
[31,38]. Thus, we tested l iposomes containing Chol and we 
added NPPE as a negatively-charged phospholipid. For a 
molar ratio PC/Cho l /NPPE 10:5:1, we obtained a longer 
T1/2 in buffer than in binary formulations (Table 1). A 
more marked stabilization effect was observed in the pres- 
ence of serum, and the leakage from PC liposomes de- 
creased 45-fold. As expected [14,25], the incorporation of 
NPPE or Chol to PC liposomes increased the trapped 
volumes (Table 1). No differences were observed in trapped 
volumes of PC/Cho l /NPPE 10:5:1, PC/Cho l  2:1 and 
PC/NPPE 10:1 vesicles. These results were confirmed by 
quasi elastic light scattering (Table 1). 
The effect of increasing NPPE concentration on the 
leakage of CF from SUV containing Chol was assessed 
next. In PBS, the incorporation of increasing amounts of 
NPPE resulted in a progressive increase in T1/2 but from 
10 mol% NPPE no significant improvement was observed 
(Table 1). In the presence of serum, optimal values were 
obtained when the molar fraction of NPPE was 15-22% 
(Table 1). Incorporation of increasing amounts of NPPE 
considerably enhanced liposome entrapped volumes and 
these values were in agreement with the sizes obtained by 
dynamic light scattering (Table 1). 
Increase in liposomes ize produces a fall in permeabil- 
ity and makes liposomes less susceptible to the action of 
serum components [39]. The T1/2 of liposomes prepared 
by the extrusion method increases as size increases, at least 
up to 200 nm, and were longer than those obtained for 
SUV (Tables 1 and 2). 
In order to determine whether the leakage decrease 
from liposomes containing NPPE was attributed only to its 
negative charge, we replaced NPPE by other lipids with 
negative charge like GM1 or phosphatidylserine (PS), 
which stabilize liposomes in vitro [14]. No difference was 
observed in buffer; GM1 and NPPE showed a similar 
effect and PS had a smaller stabilizing effect on liposomes 
Table 2 
Importance ofnegative charge and liposome size on the stability of NPPE liposomes 
Lipid composition T1/2 (h) a 
(molar atio) buffer serum 
Dme an a 
(nm) 
Trapped volume a 
(l/mol) 
PC/Chol/NPPE 10:5:1 69.9 + 8.1 27.5 + 3.4 59.7 + 3.8 0.66 + 0.14 
PC/Chol/PS 10:5:1 46.7 + 7.6 10.1 + 1.1 n.d. 0.53 + 0.12 
PC/Chol/GM1 10:5:1 55.7 + 6.6 12.5 + 0.8 n.d. 0.66 + 0.11 
PC/Chol 2:1 
LUV 0.1 p.m 90.8 + 7.3 36.9 + 5.0 104 +7.5 1.39 + 0.16 
PC/Chol/NPPE 10:5:1 
LUV 0.1 /zm 113.6 + 9.5 68.6 5:5.0 96.6 + 4.5 1.52 + 0.13 
LUV 0.2 ~m 113.1 + 6.6 88.3 _+ 5.0 133.6 + 5.1 2.57 + 0.22 
LUV 0.4 gtm 96.5 + 8.9 81.6 + 6.1 314.4 + 9.9 3.45 + 0.19 
a Results are expressed as means + S.D. (n > 5), n = number of assays. 
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Table 3 
Modulation of NPPE containing liposomes stability related to membrane fluidity and presence of GM1 
285 
Lipid composition T1/2 (h) Dmean 
(molar atio) buffer serum (nm) 
Trapped volume 
(1/mol) 
HPC/Chol/NPPE 4:3:2 
SPH/Chol/NPPE 4:3:2 
PC/SPH/Chol/NPPE 2:2:3:2 
PC/SPH/Chol/NPPE 5:5:5:1 
PC/Chol/NPPE/GM1 10:5:1:1 
PC/Chol/NPPE/GM1 4:3:2:1 
47.0 + 3.6 67.1 + 10.0 n.d. n.d. 
95.2 + 15.0 116.6 + 13.5 94.6 + 3.0 1.38 + 0.15 
97.5 + 6.6 125.1 + 11.7 84.0 + 2.2 0.93 + 0.11 
52.9 + 5.6 60.3 + 2.3 58.5 + 3.4 0.60 ___ 0.08 
54.1 _+ 6.0 40.7 + 3.6 57.9 + 3.0 0.65 + 0.10 
96.0 + 14.1 122.2 + 17.9 86.1 + 3.4 0.94 + 0.12 
a Results are expressed as means + S.D. (n > 5), n = number of assays. 
than the other two negatively-charged lipids. However, in 
the presence of serum liposomes containing NPPE had a 
higher T1/2 than liposomes with GM1 or PS (Table 2). 
3.2. Effect of membrane fluidity and presence of GM1 on 
the stability of NPPE containing liposomes 
Liposomes composed by hydrogenated eggPC (HPC), 
Chol and NPPE, in a 4:3:2 molar ratio, showed a higher 
leakage than PC/Cho l /NPPE 4:3:2 vesicles in buffer and 
in serum (Tables 1 and 3). This could be related to these 
liposomes are in a gel phase at 37 ° C and some membrane 
imperfections which decrease their stability can appear. 
When we used sphingomyelin (SPH) as rigidifying compo- 
nent, the total or partial substitution of PC by SPH in 
PC/Cho l /NPPE 4:3:2 liposomes had no significant effect 
on leakage (Table 3). However, when the NPPE concentra- 
tion was lower (6.25 mol%), incorporation of SPH in a 
molar ratio SPH:PC 1:1 had a greater stabilizing effect in 
the presence of serum. The SPH effect was not related to 
size modifications since no changes in trapped volumes or 
in l iposome size were observed (Table 3). 
It has been shown that the incorporation of GM1 stabi- 
lizes l iposomes in vitro [14] and in vivo [12,38]. In buffer, 
the 1"1/2 values obtained in the presence of GM1 were 
similar to those obtained in its absence (Table 3). In 
serum, the incorporation of 6 mol% GM1 to l iposomes 
containing 6 mol% NPPE enhanced T1/2 1.5-fold. The 
increase was lower when GM1 was incorporated to lipo- 
somes with a higher NPPE concentration (Table 3). 
3.3. Interaction of liposomes with serum components 
NPPE may reduce the serum induced destabilization of
liposomes by providing a steric barrier due to a higher 
hydration of headgroup [22,23]. To test this hypothesis, we 
have studied the agglutination, induced by streptavidin, of 
l iposomes containing biotin-cap-PE measuring the increase 
of sample turbidity. The agglutination requires a close 
apposition of the neighbouring liposomes and thus the 
decrease in turbidity, compared to control liposomes, di- 
rectly reflects the degree of steric barrier produced on the 
liposome surface. These experiments (Fig. 1) show that 
introduction of NPPE (6% or 22%) in PC/Cho l  2:1 lipo- 
somes does not inhibit l iposome agglutination. However 
GM1, as was described previously [8], produced an impor- 
tant decrease in turbidity. 
The binding of serum proteins to the liposome surface 
depends on the liposome composition and affects l iposome 
stability [30,32,40]. Liposomes of different lipid composi- 
tions (PC, PC/Cho l  2:1, PC /Cho l /NPPE 4:3:2) were 
incubated for 1 h with serum at 37°C and isolated from 
other serum components on a discontinuous Ficoll gradient 
and analyzed. 
Different amounts of protein were bound to l iposomes 
(Table 4). As expected [40]), the presence of Chol de- 
Table 4 
Influence of lipid composition on protein binding and membrane fluidity of serum-treated liposomes 
Lipid composition Liposome Protein/lipid ratio a 
(molar atio) treatment (mg protein/mg lipid) 
Fluorescence anisotropy a 
DPH TMA-DPH 
PC PBS n.d. 0.067 + 0.003 
serum 0.142 ___ 0.025 0.069 + 0.005 
serum then trypsin 0.023 + 0.006 0.071 + 0.003 
PC/Chol 2:1 PBS n.d. 0.148 ___ 0.001 
serum 0.097 + 0.013 0.148 + 0.001 
serum then trypsin 0.019 + 0.009 0.153 + 0.005 
PC/Chol/NPPE 4:3:2 PBS n.d. 0.167 + 0.002 
serum 0.094 ___ 0.011 0.170 ___ 0.003 
serum then trypsin 0.022 _+ 0.006 0.182 + 0.004 
0.212 
0.215 
0.214 
0.227 
0.243 
0.237 
0.225 
0.232 
0.242 
_+ 0.007 
_+ 0.006 
+ 0.005 
_+ 0.008 
+ 0.007 
+ 0.006 
+ 0.004 
+ 0.006 
+ 0.008 
a Results are expressed as means + S.D. (n > 3), n = number of assays. 
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Fig. 1. Effect of NPPE on the strcptavidin-induced agglutination of 
liposome containing N-biotinyl-PE. The turbidity increase (absorbance at
440 nm) was measured with time for PC/Chol 2:1 (©), PC/Chol/NPPE 
10:5:1 (v ), PC/Chol/NPPE 4:3:2 (O) and PC/Chol/GM1 0:5:1 ( • ) 
liposomes. 
creases the bound protein and the protein/lipid ratio was 
about 66% of that obtained for PC-liposomes. The incor- 
poration of NPPE does not significantly change the protein 
bound to liposomes. The profile of protein associated with 
liposomes depends only slightly on the liposome composi- 
tion, in the electrophoretic conditions used (data not show). 
On the other hand, lipid exchange and/or transfer 
between liposomes and other serum components, espe- 
cially HDL, can result in loss of encapsulated material, 
liposome disintegration, or both [4]. Lipids of serum-treated 
liposomes were separated by thin-layer chromatography 
and compared with those of non-treated liposomes. In 
every sample assessed, the lipid composition of serum- 
treated liposomes was more complex than the original 
composition. In comparison with the lipids extracted from 
serum, the chromatogram reveals that SPH, lysoPC and 
neutral lipids are incorporated to liposomes (data not 
shown). With PC/Chol 2:1 liposomes, a decrease in the 
lipid molar ratio after serum incubation was observed 
(PC/Chol = 1.6). This fact was also observed in the case 
of PC/Chol/NPPE 4:3:2 liposomes. The PC/NPPE mo- 
lar ratio was 1.7 and the PC/Chol ratio was 1.2, and the 
NPPE/Chol ratio remained constant at 0.65. This result 
was in agreement with PC being the phospholipid which 
mainly exchanges/transfers. The ratio of the total 
phospholipids to (SPH + lysoPC) incorporated to serum- 
incubated liposomes increases in order of PC < PC/Chol 
2:1 < PC/Chol/NPPE 4:3:2. It seems that the presence of 
NPPE decreases the net transfer of serum phospholipids. 
The association of proteins with liposomes could mod- 
ify the membrane fluidity and its the stability in the 
presence of serum, as has been observed for dioleolylphos- 
phatidylethanolamine/oleic ac d liposomes [30,41]. We 
examined this possibility by measuring the fluorescence 
depolarization of DPH, in order to determine whether any 
serum protein was inserted in the hydrophobic area and 
altered the bilayer fluidity. As expected, Chol and NPPE 
increase the values of the anisotropy of non-treated PC 
liposomes (Table 4). We obtained similar anisotropy val- 
ues for liposomes before and after incubation with serum, 
in every lipid composition assessed. Fluorescence depolar- 
ization of TMA-DPH was also measured to determine 
whether proteins were inserted in a more hydrophilic area 
(Table 4). No change between liposomes incubated or 
before incubation were observed. We have also incubated 
these liposomes with trypsin and determined the protein 
bound. This treatment removed the majority of proteins 
originally associated with liposomes and the anisotropy of 
membrane was unaltered, as expected (Table 4). 
4. Discussion 
Liposomes have been proposed as useful drug delivery 
systems. They are biodegradable and produce minimal 
toxicity, but they can be destabilized in biological fluids 
and eliminated from the bloodstream by MPS [12]. Lipid 
composition influences the stability of liposomes in vitro 
[14] and in vivo [8,42]. 
In the present work, we studied the inclusion of NPPE 
in the bilayer composition with the aim of obtaining 
liposomes with a high half-life. In vitro, addition of NPPE 
to PC liposomes gives a stabilizing effect, which is greater 
in serum, where PC liposomes are rapidly destabilized 
(Table 1). Increasing the NPPE molar fraction in PC 
liposomes decreases the leakage from them (Table 1). 
Besides, addition of 25 mol% NPPE to PC liposomes can 
produce a similar decrease in serum-induced leakage to 
that produced by addition of 33 mol% Chol which has 
been widely used to stabilize liposomes [30,31]. Chol and 
NPPE have a synergistic effect at the molar ratio of 
PC/Chol/NPPE 10:5:1. In PC/Chol/NPPE liposomes, 
T1/2 in buffer and in the presence of serum increases when 
NPPE concentration rises up to 22 mol%. This increase is 
hyperbolic in buffer and sigmoidal in serum. T1/2 at the 
saturation point was higher in serum than in buffer (data 
not shown). We did not test NPPE higher concentrations 
since a excess of negatively charged surface is not advis- 
able [14]. 
The stabilization of NPPE-containing liposomes in 
serum can be attributed to different factors uch as changes 
in fluidity, vesicle size and vesicle surface [25]. It could 
also be related to the limited exchange of this liposomes 
with HDL due to this fact that N-acylPE is found in small 
amounts in vivo [16]. 
NPPE produces an increase in liposome rigidity as 
demonstrated by fluorescence polarization of DPH (Table 
4). This rise in rigidity is due to the long saturated N-acyl 
chain of NPPE which penetrates deeply into the hydropho- 
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bic moiety, decreases the mobility of chains and provides a
decrease in permeability [25]. The no increase in the 
half-life of liposomes containing 22 mol% NPPE by inclu- 
sion of more rigid lipids (HPC and SPH) suggest an 
optimal membrane fluidity since stabilization effect by 
inclusion of SPH was observed at lower molar fraction of 
NPPE (Table 3). 
In accordance with previous results, the susceptibility of
liposomes to the action of serum components decreases 
when liposome size increases [39] so the T1/2 of 
PC/Chol/NPPE 10:5:1 liposomes prepared by the extru- 
sion method increases as size increases (Table 2). How- 
ever, the stability of NPPE containing liposomes cannot be 
only assigned to the size increase, since PC/Chol/NPPE 
10:5:1 LUV 100 nm have a higher half-life than PC/Chol 
LUV 100 nm even though they have similar size (Table 2) 
and both have half-life lower than sonicated liposomes 
containing 22 mol% NPPE and sized near 100 nm, which 
is considered a suitable size for in vivo studies [13] (Table 
1). 
The surface charge is an important parameter which 
contributes to liposome stability [43,44]. The importance 
of the negative charge of NPPE has been pointed out since 
we observed that the introduction of NPPE into PC/Chol 
liposomes allows to achieve a longer half-life in vitro than 
that of a negatively-charged PS or a shielded negative- 
charged GM1 (Table 2). NPPE does not have a bulky 
group to protect he negative charge but this phospholipid 
presents the phosphate group highly hydrated [22]. The 
possibility of a steric barrier presented by NPPE is elimi- 
nated since no inhibition of the agglutination of liposomes 
containing biotin-cap PE, mediated by streptavidin, was 
observed in liposomes containing NPPE (Fig. 1). The 
absence of a steric barrier does not rule out the possibility 
that NPPE containing liposomes could be useful for in 
vivo applications, as has been demonstrated forGM1 [45]. 
Moreover, the surface modification produced by NPPE 
could maybe modify the interaction with serum compo- 
nents [7]. 
The exchange/transfer of phospholipids between lipo- 
somes and lipoproteins produce the incorporation to lipo- 
somes of SPH and lyso-PC, which decreases by the pres- 
ence of Chol and NPPE (data not shown). NPPE/Chol 
ratio does not change after serum incubation, which indi- 
cates that probably neither NPPE nor Chol transfer has 
been produced. This could be another factor which con- 
tributes to the stabilization of liposomes containing NPPE. 
The interactions with serum proteins can affect the 
stability of liposomes [46,47]. In our case, the introduction 
of Chol into PC liposomes decreases the association of 
protein by 33% (Table 4), in accord with previous tudies 
[3,40]. The same amount and electrophoretic profile of 
proteins bound to PC/Chol 2:1 liposomes has been ob- 
served in PC/Chol/NPPE liposomes (Table 4 and data 
not shown), however these liposomes are more stable. 
These proteins associated with liposomes are accessible to 
trypsin and no increase in membrane rigidity, either in the 
hydrophobic moiety, measured by DPH, or in the more 
hydrophilic area, measured by TMA-DPH, was observed 
after serum incubation (Table 4). Therefore, these proteins 
do not seem responsible for stabilization of liposomes 
containing NPPE. However, we do not rule out the possi- 
bility that some low molecular proteins, which are not 
detected in our electrophoretic conditions, could be the 
responsible for the stabilization of liposomes containing 
NPPE. 
In summary, we have obtained a ternary liposome 
formulation PC/Chol/NPPE including 10-22 mol% of 
NPPE which is greatly stable in the presence of serum. 
The reason for this stabilization is not attributed to a single 
factor because probably different parameters described in 
this paper are involved. In forecoming studies, we will test 
the behaviour of these liposomes in vivo to assess that this 
liposome formulation is useful as a drug carrier system. In 
this context, we have observed that the introduction of 
GM1 has no important effect on 1"1/2 in vitro at a higher 
molar fraction of NPPE (Table 3). Therefore, if NPPE 
liposomes do not evade RES, the incorporation of GM1 
which produces a modification in the liposome surface 
would permit he evasion of RES [48]. 
Acknowledgements 
This work was supported by Grant No. 91/0398 from 
F.I.S.S.S. (Spain). 
References 
[1] Gregoriadis, G. (1988) Liposomes as Drug Carders: Recent Trends 
and Progress, J. Wiley and Sons, New York. 
[2] Juliano, R.L. (1989) in Drug Carder Systems (Roerdink, F.H.D. and 
Kroon, A.M., eds.), John Wiley and Sons, New York. 
[3] Damen, J., Regts, J. and Scherphof, G. (1981) Biochim. Biophys. 
Acta 665, 538-545. 
[4] Allen, T.M. (1981) Biochim. Biophys. Acta 640, 385-397. 
[5] Moghimi, S.M. and Patel, H.M. (1989) Biochim. Biophys. Acta 984, 
379-385. 
[6] Allen, T.M., Austin, G.A., Chonn, A., Lin, L. and Lee, K.C. (1991) 
Biochim. Biophys. Acta 1061, 56-64. 
[7] Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, 
A. (1991) Biochim. Biophys. Acta 1066, 29-36. 
[8] Park, Y.S., Maruyama, K. and Huang, L. (1992) Biochim. Biophys. 
Acta 1108, 257-260. 
[9] Chobanian, J.V., Tall, A.R. and Brecher, P.I. (1979) Biochemistry 
18, 180-187. 
[10] Jonas, A. and Maine, G.T. (1979) Biochemistry 18, 1722-1728. 
[11] Pownall, H.J., Massey, J.B., Kusserow, S.K. and Gotto, A.M. (1979) 
Biochemistry 18, 180-187. 
[12] Allen, T.M. and Chonn, A. (1987) FEBS Lett. 223, 42-46. 
[13] Allen, T.M., Hansen, C. and Rutledge, J. (1989) Biochim. Biophys. 
Acta 981, 27-35. 
[14] Allen, T.M., Ryan, J.L. and Papahadjopoulos, D. (1985) Biochim. 
Biophys. Acta 818, 205-210. 
[15] Woodle, M.C. and Lasic, D.D. (1992) Biochim. Biophys. Acta 1113, 
171-199. 
288 M. Mercadal et al. / Biochimica et Biophysica Acta 1235 (1995) 281-288 
[16] Schmid, H.H.O., Schmid, P.C. and Natarajan, V. (1990) Prog. Lipid 
Rcs. 29, 1-43. 
[17] Matsumoto, M. and Miwa, M. (1973) Biochim. Biophys. Acta 296, 
350-364. 
[18] Gray, G.M. (1976) Biochim. Biophys. Acta 431, 1-8. 
[19] Epps D.E., Schmid, P.C., Natarajan, V. and Schmid, H.H.O. (1979) 
Biochem. Biophys. Res. Commun. 90, 628-633. 
[20] Epps, D.E., Natarajan, V., Schmid, P.C. and Schmid, H.H.O. (1980) 
Biochim. Biophys. Acta 618, 420-430. 
[21] Akoka, S., Tellier, C., Le Roux, C. and Marion, D. (1988) Chem. 
Phys. Lipids 46, 43-50. 
[22] Lafrance, D., Marion, D. and Przolet, M. (1990) Biochemistry 29, 
4592-4599. 
[23] Domingo, J.C., Mora, M. and De Madariaga, M.A. (1994) Chem. 
Phys. Lipids 69, 229-240. 
[24] Newman, J.L., Stiers, D.L., Anderson, W.H. and Schmid, H.H.O. 
(1986) Chem. Phys. Lipids 42, 249-260. 
[25] Domingo, J.C., Mora, M. and De Madariaga, M.A. (1993) Biochim. 
Biophys. Acta 1148, 308-316. 
[26] Domingo, J.C., Mora, M. and De Madariaga, M.A. (1989) Biochem. 
Soc. Trans. 17, 997-999. 
[27] Rouser, G., Fleischer, S. and Yamamoto, A. (1970) Lipids 5, 
494-496. 
[28] Nayar, R., Hope, M.J. and Cullis, P.R. (1989) Biochim. Biophys. 
Acta 986, 200-206. 
[29] Stewart, J.M.C. (1980) Anal, Biochem. 104, 10-14. 
[30] Liu, D. and Huang, L. (1989) Biochemistry 28, 7700-7707. 
[31] Allen, T.M. and Cleland, L.G. (1980) Biochim. Biophys. Acta 597, 
418-426. 
[32] Bontr, F., Hsu, M.J., Papp, A., Wu, K., Regen, S.L. and Juliano, 
R.L. (1987) Biochim. Biophys. Acta 900, 1-9. 
[33] Laemmli, V.K. (1970) Nature 227, 680-685. 
[34] Kates, M. (1986) in Techniques of Lipidology (Burdon, R.H. and I
Van Knippenberg, P.H., eds.), Elsevier, Amsterdam. 
[35] Sale, F.O., Marchesini, S., Fishman, P.H. and Berra, B. (1984) Anal. 
Biochem. 142, 347-350. 
[36] Chonn, A., Semple, S.C. and Cullis, R. (1991) Biochim. Biophys. 
Acta 1070, 215-222. 
[37] Shinitzky, M. and Barenholz, Y. (1974) J. Biol. Chem. 249, 2652- 
2657. 
[38] Gabizon, G. and Papahadjopoulos, D. (1988) Proc. Natl. Acad. Sci. 
USA 85, 6949-6953. 
[39] Scherphof, G. and Morselt, H. (1984) Biochem. J 221, 423-429. 
[40] Hermindez-Caselles, T., Villalaln, J. and Grmez-Fern~ndez, J.C. 
(1993) Mol. Cel. Biochem. 120, 119-126. 
[41] Liu, D. and Huang, L. (1989) Biochim. Biophys. Acta 981, 254-260. 
[42] Davis, C. and Gregoriadis, G. (1979) Biochem. Soc. Trans. 7, 
680-682. 
[43] Gamon, B.L., Virden, J.W. and Berg, J.C. (1989) J. Colloid Inter- 
face Sci. 132, 125-138. 
[44] Crommelin, D.J.A. (1984) J. Pharm. Sci. 73, 1559-1563. 
[45] Mori, A., Klibanov, A.L., Torchilin, V.P. and Huang, L. (1991) 
FEBS Lett. 284, 263-266. 
[46] Bontr, F. and Juliano, R.L. (1986) Chem. Phys. Lipids 40, 359-372. 
[47] Liu, D., Zhou, F. and Huang, L. (1989) Biochem. Biophys. Res. 
Comm. 162, 326-333. 
[48] Liu, D., Mori, A. and Huang, L. (1991) Biochim. Biophys. Acta 
1066, 159-165. 
